DANIEL FAZZINO: Open Payments
NPI 1013496892 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 53 payments from 12 companies in 2025. Trend: 2023 $1,603 · 2024 $1,133 · 2025 $1,351
Food & beverage: $1,351
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 26 | $619 |
| Gilead Sciences, Inc. | 16 | $349 |
| Botanix SB Inc | 1 | $150 |
| EMD Serono, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $29 |
| Alkermes, Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Napo Pharmaceuticals Inc | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: DOVATO, SOFDRA, APRETUDE, Biktarvy, INGREZZA, PANTHER FUSION, VIVITROL, Oxistat.
Industry payments across CA — which companies pay providers there.
